Improvement of primary Sjögren’s syndrome salivary gland function by Xinfeng capsule and its effect on EGR1-STAT3 signaling pathway
XFC demonstrated a significant improvement in the salivary secretion function of the SG in pSS mice. EGR1 can serve as a biomarker and therapeutic target for pSS.
Authors
- Gangli Cheng
- Su Bu (ORCID: https://orcid.org/0000-0002-3232-8663)
- Xingxing Huo (ORCID: https://orcid.org/0000-0002-0928-9766)
- Beijia Wang (ORCID: https://orcid.org/0009-0005-8674-5170)
- Pingping Li (ORCID: https://orcid.org/0000-0003-0679-270X)
- Xiaoting Qiu
- S. Bian (ORCID: https://orcid.org/0009-0003-6056-8079)
- Ling Zhu (ORCID: https://orcid.org/0000-0002-6391-733X)
- Jian Liu (ORCID: https://orcid.org/0009-0000-3601-6870)
Institutions
- Anhui Medical University (CN)
- Anhui University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1093/jpp/rgae121
- Citations
- 1
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.33
Funders
- National Natural Science Foundation of China